Clinical Trial Update: Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma [Phase 3]

View source ↗

Summary

Phase 3 study of fotemustine given intravenously or by hepatic arterial infusion for unresectable liver metastases from intraocular melanoma; the trial is termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Intraocular Melanoma

Drugs mentioned

• Fotemustine (fotemustine)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Intraocular Melanoma, Metastatic Cancer | Phase 3 | Status: TERMINATED